Primerry is a Mumbai-based paediatric health-tech startup. Primerry has successfully raised ₹7.1 crore (approximately $760,000) in its pre-seed funding round. During the funding round, there was a remarkable presence of a seasoned investor in the person of Ashish Kacholia, along with Lashit Sanghvi. The injection of fresh capital will give enough financial support to the company as it seeks to carve out a niche in the fast-growing Indian pediatric care market space. The success of the company in raising funds is an indication of investor faith in its business model and strategy towards solving basic problems in children’s health care.

Product portfolio strategy

Primerry was established by Rushabh Nandu and Dr Nihar Parekh to create a simpler, safer, and more reliable experience of everyday healthcare for parents and children. The startup emphasizes the development of clean label, clinically proven formulations focused exclusively on young children’s daily health and wellness requirements. 

To meet the varied paediatric health needs, Primerry will focus on providing an initial full selection of 8 stock-keeping units, known as SKUs. These first health care products will command a market price of between ₹499 and ₹1,499, making high-quality, scientifically tested paediatric solutions available to a diverse and modern consumer base.

Omnichannel vision and operational expansion

The amount raised is ₹7.1 crore, and the funds will be used strategically across multiple operating platforms to help the company move into its next growth cycle. A significant part of the funding will be allocated towards either enhancing the core product development capabilities or augmenting the internal clinical knowledge and supporting research program. 

Primerry will allocate resources to establish solid supply chain operations and expand its footprint across the country. The startup will be releasing the product line in a variety of sales channels, starting with its digital platform for direct-to-consumer sales. In its first operational year, Primerry intends to expand its offering to other quick commerce delivery services so that parents can access it quickly.

Beyond online transactions, Primerry is focusing on making a significant offline footprint to create meaningful consumer trust and retail availability. The company will look to sell its products directly through physical stores, particularly in its partnered pharmacy locations, paediatric specialty centers, and dedicated mom-and-baby specialty stores. 

The first stage of this physical retail expansion will be in Tier-1 cities and Indian mega metropolises where the demand for premium and clinically proven child wellness products is the highest. With online direct-to-consumer availability and the application of quick-commerce fulfillment through technology that can integrate offline medical retail distribution, Primerry can attempt to build an omnichannel infrastructure that is able to reach parents wherever they are looking for healthcare solutions.

Conclusion

The funds raised in the pre-seed round of ₹7.1 crore bring Primerry a major step closer to entering the paediatric health-tech domain. The company has already secured backing from experienced investors such as Ashish Kacholia and Lashit Sanghvi, and the collective expertise of co-founders Rushabh Nandu and Dr. Nihar Parekh suggests that the startup can meet its growth goals. Primerry fulfills an important void in the child wellness category by bringing to market an initial SKU launch of 8 products that are clinically proven, clean label, and range from ₹499 to ₹1,499. With its growing presence in D2C, quick commerce, and offline clinical networks in tier-1 cities and metros, the company is poised to make everyday paediatric healthcare easier for families in India.